Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Connealy Pamela Ann. Insider active across 2 companies, notably Orchestra BioMed Holdings, Inc.. Cumulatively, 13 reports have been recorded. Breakdown: 5 buys · 0 sell. Total volume traded: €63k. Activity tracked since 20 July 2023. The latest transaction was disclosed on 7 August 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Connealy Pamela Ann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11,667 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-23-083499:0
13 of 13 declarations
About Connealy Pamela Ann
Connealy Pamela Ann is a declarant with 13 filings in total. The 13 sampled filings, covering the period from 2023-07-24 to 2026-06-25, show EUR 62976 in buys and EUR 0 in sells, with the modal transaction nature listed as Attribution. She is linked to Pyxis Oncology, Inc. as CFO & COO and to Orchestra BioMed Holdings, Inc. as Director.